Skip to main content
. 2021 Apr 1;66:103308. doi: 10.1016/j.ebiom.2021.103308

Fig. 5.

Fig. 5

Memory B cell responses. S. flexneri 2a LPS-specific memory B cell ALS IgG (a) and IgA (b) geometric mean ELISA endpoint titres with 95% confidence intervals at baseline (day 0), day of challenge (day 56) and 28 days post-challenge (day 84), grouped by vaccinated or placebo subjects. * = significant difference as compared to baseline titres within treatment group as determined by repeated measures ANOVA of log-transformed titres with Bonferroni post-hoc test.